Nitric oxide production and inducible nitric oxide synthase expression by monocytes in systemic sclerosis;Expression de la NO synthase inductible et production du monoxyde d'azote par les cellules mononucléées sanguines dans la sclérodermie systémique

Bulletin de l'Academie Nationale de Medecine

Volumn 185, Issue 3, 2001, Pages 509-523

  Menkès, Charles Joël ^b   Allanore, Yannick ^b   Borderie, Didier ^a   Hilliquin, Pascal ^b   Hernvann, Alain ^a   Ekindjian, Ohvanesse ^a   Kahan, André ^b  

^a Hôpital Cochin ^*  (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CASE CONTROL STUDY; CELL CULTURE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FLUOROMETRY; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; ISCHIALGIA; METABOLISM; MONOCYTE; PHYSIOLOGY; PROGNOSIS; RHEUMATOID ARTHRITIS; SPECTROPHOTOMETRY; SYSTEMIC SCLEROSIS;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FLUOROMETRY; HUMANS; IMMUNOBLOTTING; MONOCYTES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROGNOSIS; SCIATICA; SCLERODERMA, SYSTEMIC; SPECTROPHOTOMETRY;

EID: 0035228132     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)34536-4     Document Type: Article

References (45)

1. KAHAN A., DEVAUX J.Y., AMOR B., MENKÈS C.J., WEBER S., NITENBERG A., VENOT A., GUERIN F., DEGEORGES M., ROUCAYROL J.C. - Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N. Engl. J. Med., 1986, 22,1397-1402.
2. KAHALEH M.B. - Endothelin, an endothelial-dependent vasoconstrictor in scleroderma : enhanced production and profibrotic action. Arthritis Rheum., 1991, 34, 978-983.
3. KAHALEH B., MATUCCI-CERENIC M. - Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum., 1995, 38, 1-4.
4. CANNON R.O. - Role of nitric oxide in cardiovascular disease : focus on the endothelium. Clin. Chem., 1998, 44, 1809-1819.
5. SUZUKI M., OGAWA A., ASAHARA H., ENDO S., INADA K. - Nitric oxide and vasospasm. J Neurosurg., 1997, 4, 741-742.
6. ARTIGUES C., RICHARD V., THUILLEZ C. - Evaluation of the effects of experimental hypertension on monocyte-endothelial cell interactions. Arch. Mal. Cœur Vaiss., 1998, 8, 1031-1034.
7. KAHALEH M.B. - Lymphocyte interactions with the vascular endothelium in systemic sclerosis. Clin Dermatol., 1994, 12, 361-367.
8. KAHALEH M.B. - Soluble immunologic products in scleroderma sera. Clin. Immunol. Immunopathol., 1991, 58, 139-144.
9. PRESCOTT R.J., FREEMONT A.J., JONES C.J., HOYLAND J., FIELDING P. - Sequential dermal microvascular and perivascular changes in the development of scleroderma. J. Pathol., 1992, 166, 255-263.
10. ROUMM A.D., WHITESIDE T.L., MEDSGER T.A. JR, RODNAN G.P. - Lymphocytes in the skin of patients with progressive systemic sclerosis. Arthritis Rheum., 1984, 27, 645-653.
11. DENTON C.P., SHI-WEN X., SUTTON A., ABRAHAM D.J., BLACK C.M., PEARSON J.D. - Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers. Clin. Exp. Immunol., 1998, 114, 293-300.
12. FARRELL A.J., BLAKE D.R. - Nitric oxide. Ann. Rheum. Dis., 1996, 55, 7-20.
13. KOLB H., KOLB-BACHOFEN V. - Nitric oxide in autoimmune disease : cytotoxic or regulatory mediator? Immunol. Today, 1998, 19, 556-561.
14. DUGAS B., MOSSALAYI M.D., DAMAIS C., KOLB J.P. - Nitric oxide production by human monocytes : evidence for a role of CD23. Immunol. Today, 1995, 16, 574-580.
15. KANTOR T.V., FRIBERG D., MEDSGER T.A., BUCKINGHAM R.B., WHITESIDE T.L. - Cytokine production and serum levels in systemic sclerosis. Clin. Immunol. Immunopathol., 1992, 65, 278-285.
16. NEEDELMAN B.W., WIGLEY F.M., STAIR R.W. - Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α and interferon γ levels in sera from patients with scleroderma. Arthritis Rheum., 1992, 35, 67-72.
17. ROSENBLOOM J., FELDMAN G., FREUNLICH B., JIMENEZ S.A. - Inhibition of excessive scleroderma fibroblast collagen production by recombinant γ interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels. Arthritis Rheum., 1986, 29, 851-856.
18. Subcommittee for Scleroderma Criteria of The American Rheumatism Association. Diagnostic and Therapeutic Criteria Committee. - Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum., 1980, 23, 581-590.
19. LEROY E.C., BLACK C., FLEISCHMAJER R., JABLONSKA S., KRIEG T., MEDSGER T.A. JR, ROWELL N., WOLLHEIM F. - Scleroderma (systemic sclerosis) : classification, subsets and pathogenesis. J. Rheumatol., 1988, 15, 202-205.
20. SAINT-CLAIR E.W., WILKINSON W.E., LANG T., SANDERS L., MISUKONIS M.A., GILKESON G.S., PISETSKY D.S., GRANGER D.L., WEINBERG J.B. - Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J. Exp. Med., 1996, 184, 1173-1178.
21. ARNETT F.C., EDWORTHY S.M., BLOCH D.A., MCSHANE D.J., FRIES J.F., COOPER N.S., HEALEY L.A., KAPLAN S.R., LIANG M.H., LUTHRA H.S. et al. - The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum., 1988, 31, 315-324.
22. 15N)nitrate in biological fluids. Anal. Biochem., 1982, 126, 131-138.
23. CARTER L., SWAIN S.L. - Single cell analysis of cytokine production. Curr. Opin. Immunol., 1997, 9, 177-182.
24. GRABOWSKI P.S., ENGLAND A.J., DYKHUIZEN R., COPLAND M., BENJAMIN N., RELD D.M., RALSTON S.H. - Elevated nitric oxide production in rheumatoid arthritis. Arthritis Rheum., 1996, 39, 643-647.
25. HILLIQUIN P., BORDERIE D., HERNVANN A., MENKÈS C.J., EKINDJIAN O.G. - Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum., 1997, 40, 1512-1517.
26. AEBERHARD E.E., HENDERSON S.A., ARABOLOS N.S., GRISCAVAGE J.M., CASTRO F.E., BARRETT C.T. - Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem. Biophys. Res. Commun., 1995, 208, 1053-1059.
27. OMATA T., SEGAWA Y., INOUE N., TSUZUIKE N., ITOKAZU Y., TAMAKI H. - Methotrexate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis. Res. Exp. Med., 1997, 197, 81-90.
28. SZABO C., MITCHELL J.A., GROSS S.S., THIEMERMANN C., VANE J.R. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharride. J. Pharmacol. Exp. Ther., 1993, 265, 674-680.
29. ZHANG X., HINTZE T. H. Amlodipine releases nitric oxide from canine coronary microvessels. Circulation, 1998, 97, 576-580.
30. KAHALEH M.B., PAN-SHENG F., MATUCCI-CERENIC M., STEFANOVIC-RACIC M., IGNARRO L. Study of endothelial dependent relaxation in scleroderma. Arthritis Rheum., 1993, 36, S, 180.
31. YAMAMOTO T., KATAYAMA I., NISHIOKA K. - Nitric oxide production and inducible nitric oxide synthase expression in systemic scleroderma. J. Rheumatol., 1998, 25, 314-317.
32. UEKI Y., MIYAKE S., TOMINAGA Y., EGUCHI K. - Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol., 1996, 23, 230-236.
33. BENJAMIN N., VALLANCE P. Plasma nitrite as a marker of nitric oxide production. Lancet, 1994, 344, 960.
34. KAHALEH M.B., PAN-SHENG F. - Down regulation of nitric oxide synthase in microvascular endothelial cells from lesional scleroderma : assessment by quantitative RT-PCR and possible role for cytotoxic T-cells. Arthritis Rheum., 1998, 41, S, 277.
35. ORMAN K.L., SHENEP J.L., ENGLISH B.K. Pneumococci stimulate the production of the inducible nitric oxide synthase and nitric oxide by murine macrophages. J. Infec. Dis., 1998, 6, 1649-1657.
36. WEINBERG J.B., MISUKONIS M.A., SHAMI P.J., MASON S.N., SAUIS D.L., DITTMAN W.A., WOOD E.R., SMITH G.K., MCDONALD B., BACHUS K.E., et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS) : analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood, 1995, 86, 1184-1195.
37. ARIAS M., ZABALETA J., RODRIGUEZ J.L., ROJAS M., PARIS S.C., GARCIA L.F. - Failure to induce nitric oxide production by human monocyte-derived macrophages. Manipulation of biochemical pathways. Allergol. Immunopathol., 1997, 6, 280-288.
38. MACMICKING J., XIE Q.W., NATHAN C. - Nitric oxide and macrophage function. Ann. Rev. Immunol., 1997, 15, 323-350.
39. YAMAMOTO T., SAWADA Y., KATAYAMA Y., NISHIOKA K. Increased production of nitric oxide stimulated by interleukin-1β in peripheral blood mononuclear cells in patients with systemic sclerosis. Br. J. Rheumatol., 1998, 37, 1123-1125.
40. CAVALLO G., SABADINI L., ROLLO L., CATENACCIO M., LORENZINI S., PIPITONE N., MARCOLONGO R. - Nitric oxide synthesis in peripheral blood mononuclear and polymorphonuclear cells from patients with systemic sclerosis. Rheumatology, 1999, 38, 1301-1304.
41. COTTON S.A., HERRICK A.L., JAYSON M.I., FREEMONT A.J. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J. Pathol., 1999, 189, 273-278.
42. FREEDMAN R.R., GIRGIS R., MAYES M.D. Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma. Lancet, 1999, 354, 739.
43. KAHAN A., AMOR B., MENKÈS C.J. - Nicardipine in the treatment of Raynaud's phenomenon. Arthritis Rheum., 1987, 30, S, 62.
44. KAHAN A., DEVAUX J.Y., AMOR B., MENKES C.J., WEBER S., VENOT A., GUERIN F., DEGEORGES M., ROUCAYROL J.C. - Nicardipine improves myocardial perfusion in systemic sclerosis. J. Rheumatol., 1988, 15, 1395-1400.
45. DHEIN S., ZHAO Y., SIMSEK S., SALAMEH A., KLAUS W. - Actions of 1,4-dihydropyridines in isolated mesenteric vascular beds. J. Cardiovasc. Pharmacol., 1995, 26, 784-791.